Telomere maintenance and DNA damage responses during lung carcinogenesis

Sylvie Lantuejoul, Christophe M. Raynaud, Dimitri Salameire, Sylvie Gazzeri, Denis Moro-Sibilot, Jean Charles Soria, Christian Brambilla, Elizabeth Brambilla

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: Telomere shortening is an early event in bronchial carcinogenesis, preceding P53/Rb pathway inactivation and telomerase reactivation, and leading to DNA damage responses (DDR). As their inactivation in cancer increases genetic instability, our objective was to identify the chronology of telomere machinery critical events for malignant progression. Experimental Design: We have evaluated telomere length by fluorescence in situ hybridization and analyzed DDR proteins p-CHK2, p-ATM, and p-H2AX, and telomeric maintenance proteins TRF1 and TRF2 expression by immunohistochemistry in normal bronchial/bronchiolar epithelium, and in 109 bronchial preneoplastic lesions, in comparison with 32 squamous invasive carcinoma (SCC), and in 27 atypical alveolar hyperplasia (AAH) in comparison with 6 adenocarcinoma in situ (AIS; formerly bronchiolo-alveolar carcinoma) and 24 invasive adenocarcinoma (ADC). Results: Telomere length critically shortened at bronchial metaplasia stage to increase gradually from dysplasia to invasive SCC; in bronchiolo-alveolar lesions, telomere length decreased from normal to AIS and increased from stage I to II to stage III to IV ADC. Expression of TRF1 and TRF2 increased progressively from dysplasia to SCC and from AAH to invasive ADC. The expression of concomitant DDR proteins increased significantly from low- to high-grade dysplasia and from AAH to AIS and stage I to II ADC. P-CHK2 and p-H2AX expressions were highly correlated and both decreased, along with p-ATM, in SCC and advanced ADC. Conclusion: Telomere attrition occurs at the earliest stage of lung carcinogenesis as an initiating event, preceding TRF1 and TRF2 overexpression for telomere stabilization. In contrast, dismiss of DDR, through p-H2AX and p-CHK2 downregulation, represents a late progressing event associated with SCC and ADC progression.

Original languageEnglish
Pages (from-to)2979-2988
Number of pages10
JournalClinical Cancer Research
Volume16
Issue number11
DOIs
Publication statusPublished - 1 Jun 2010
Externally publishedYes

Fingerprint

Telomere
DNA Damage
Carcinogenesis
Adenocarcinoma
Maintenance
Squamous Cell Carcinoma
Lung
Hyperplasia
Telomeric Repeat Binding Protein 2
Telomeric Repeat Binding Protein 1
Bronchiolo-Alveolar Adenocarcinoma
Telomere Shortening
Chronology
Telomerase
Metaplasia
Fluorescence In Situ Hybridization
Proteins
Research Design
Down-Regulation
Epithelium

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lantuejoul, S., Raynaud, C. M., Salameire, D., Gazzeri, S., Moro-Sibilot, D., Soria, J. C., ... Brambilla, E. (2010). Telomere maintenance and DNA damage responses during lung carcinogenesis. Clinical Cancer Research, 16(11), 2979-2988. https://doi.org/10.1158/1078-0432.CCR-10-0142

Telomere maintenance and DNA damage responses during lung carcinogenesis. / Lantuejoul, Sylvie; Raynaud, Christophe M.; Salameire, Dimitri; Gazzeri, Sylvie; Moro-Sibilot, Denis; Soria, Jean Charles; Brambilla, Christian; Brambilla, Elizabeth.

In: Clinical Cancer Research, Vol. 16, No. 11, 01.06.2010, p. 2979-2988.

Research output: Contribution to journalArticle

Lantuejoul, S, Raynaud, CM, Salameire, D, Gazzeri, S, Moro-Sibilot, D, Soria, JC, Brambilla, C & Brambilla, E 2010, 'Telomere maintenance and DNA damage responses during lung carcinogenesis', Clinical Cancer Research, vol. 16, no. 11, pp. 2979-2988. https://doi.org/10.1158/1078-0432.CCR-10-0142
Lantuejoul S, Raynaud CM, Salameire D, Gazzeri S, Moro-Sibilot D, Soria JC et al. Telomere maintenance and DNA damage responses during lung carcinogenesis. Clinical Cancer Research. 2010 Jun 1;16(11):2979-2988. https://doi.org/10.1158/1078-0432.CCR-10-0142
Lantuejoul, Sylvie ; Raynaud, Christophe M. ; Salameire, Dimitri ; Gazzeri, Sylvie ; Moro-Sibilot, Denis ; Soria, Jean Charles ; Brambilla, Christian ; Brambilla, Elizabeth. / Telomere maintenance and DNA damage responses during lung carcinogenesis. In: Clinical Cancer Research. 2010 ; Vol. 16, No. 11. pp. 2979-2988.
@article{3f3fd6f87c474cfc9e2608b90fd2365f,
title = "Telomere maintenance and DNA damage responses during lung carcinogenesis",
abstract = "Purpose: Telomere shortening is an early event in bronchial carcinogenesis, preceding P53/Rb pathway inactivation and telomerase reactivation, and leading to DNA damage responses (DDR). As their inactivation in cancer increases genetic instability, our objective was to identify the chronology of telomere machinery critical events for malignant progression. Experimental Design: We have evaluated telomere length by fluorescence in situ hybridization and analyzed DDR proteins p-CHK2, p-ATM, and p-H2AX, and telomeric maintenance proteins TRF1 and TRF2 expression by immunohistochemistry in normal bronchial/bronchiolar epithelium, and in 109 bronchial preneoplastic lesions, in comparison with 32 squamous invasive carcinoma (SCC), and in 27 atypical alveolar hyperplasia (AAH) in comparison with 6 adenocarcinoma in situ (AIS; formerly bronchiolo-alveolar carcinoma) and 24 invasive adenocarcinoma (ADC). Results: Telomere length critically shortened at bronchial metaplasia stage to increase gradually from dysplasia to invasive SCC; in bronchiolo-alveolar lesions, telomere length decreased from normal to AIS and increased from stage I to II to stage III to IV ADC. Expression of TRF1 and TRF2 increased progressively from dysplasia to SCC and from AAH to invasive ADC. The expression of concomitant DDR proteins increased significantly from low- to high-grade dysplasia and from AAH to AIS and stage I to II ADC. P-CHK2 and p-H2AX expressions were highly correlated and both decreased, along with p-ATM, in SCC and advanced ADC. Conclusion: Telomere attrition occurs at the earliest stage of lung carcinogenesis as an initiating event, preceding TRF1 and TRF2 overexpression for telomere stabilization. In contrast, dismiss of DDR, through p-H2AX and p-CHK2 downregulation, represents a late progressing event associated with SCC and ADC progression.",
author = "Sylvie Lantuejoul and Raynaud, {Christophe M.} and Dimitri Salameire and Sylvie Gazzeri and Denis Moro-Sibilot and Soria, {Jean Charles} and Christian Brambilla and Elizabeth Brambilla",
year = "2010",
month = "6",
day = "1",
doi = "10.1158/1078-0432.CCR-10-0142",
language = "English",
volume = "16",
pages = "2979--2988",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Telomere maintenance and DNA damage responses during lung carcinogenesis

AU - Lantuejoul, Sylvie

AU - Raynaud, Christophe M.

AU - Salameire, Dimitri

AU - Gazzeri, Sylvie

AU - Moro-Sibilot, Denis

AU - Soria, Jean Charles

AU - Brambilla, Christian

AU - Brambilla, Elizabeth

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Purpose: Telomere shortening is an early event in bronchial carcinogenesis, preceding P53/Rb pathway inactivation and telomerase reactivation, and leading to DNA damage responses (DDR). As their inactivation in cancer increases genetic instability, our objective was to identify the chronology of telomere machinery critical events for malignant progression. Experimental Design: We have evaluated telomere length by fluorescence in situ hybridization and analyzed DDR proteins p-CHK2, p-ATM, and p-H2AX, and telomeric maintenance proteins TRF1 and TRF2 expression by immunohistochemistry in normal bronchial/bronchiolar epithelium, and in 109 bronchial preneoplastic lesions, in comparison with 32 squamous invasive carcinoma (SCC), and in 27 atypical alveolar hyperplasia (AAH) in comparison with 6 adenocarcinoma in situ (AIS; formerly bronchiolo-alveolar carcinoma) and 24 invasive adenocarcinoma (ADC). Results: Telomere length critically shortened at bronchial metaplasia stage to increase gradually from dysplasia to invasive SCC; in bronchiolo-alveolar lesions, telomere length decreased from normal to AIS and increased from stage I to II to stage III to IV ADC. Expression of TRF1 and TRF2 increased progressively from dysplasia to SCC and from AAH to invasive ADC. The expression of concomitant DDR proteins increased significantly from low- to high-grade dysplasia and from AAH to AIS and stage I to II ADC. P-CHK2 and p-H2AX expressions were highly correlated and both decreased, along with p-ATM, in SCC and advanced ADC. Conclusion: Telomere attrition occurs at the earliest stage of lung carcinogenesis as an initiating event, preceding TRF1 and TRF2 overexpression for telomere stabilization. In contrast, dismiss of DDR, through p-H2AX and p-CHK2 downregulation, represents a late progressing event associated with SCC and ADC progression.

AB - Purpose: Telomere shortening is an early event in bronchial carcinogenesis, preceding P53/Rb pathway inactivation and telomerase reactivation, and leading to DNA damage responses (DDR). As their inactivation in cancer increases genetic instability, our objective was to identify the chronology of telomere machinery critical events for malignant progression. Experimental Design: We have evaluated telomere length by fluorescence in situ hybridization and analyzed DDR proteins p-CHK2, p-ATM, and p-H2AX, and telomeric maintenance proteins TRF1 and TRF2 expression by immunohistochemistry in normal bronchial/bronchiolar epithelium, and in 109 bronchial preneoplastic lesions, in comparison with 32 squamous invasive carcinoma (SCC), and in 27 atypical alveolar hyperplasia (AAH) in comparison with 6 adenocarcinoma in situ (AIS; formerly bronchiolo-alveolar carcinoma) and 24 invasive adenocarcinoma (ADC). Results: Telomere length critically shortened at bronchial metaplasia stage to increase gradually from dysplasia to invasive SCC; in bronchiolo-alveolar lesions, telomere length decreased from normal to AIS and increased from stage I to II to stage III to IV ADC. Expression of TRF1 and TRF2 increased progressively from dysplasia to SCC and from AAH to invasive ADC. The expression of concomitant DDR proteins increased significantly from low- to high-grade dysplasia and from AAH to AIS and stage I to II ADC. P-CHK2 and p-H2AX expressions were highly correlated and both decreased, along with p-ATM, in SCC and advanced ADC. Conclusion: Telomere attrition occurs at the earliest stage of lung carcinogenesis as an initiating event, preceding TRF1 and TRF2 overexpression for telomere stabilization. In contrast, dismiss of DDR, through p-H2AX and p-CHK2 downregulation, represents a late progressing event associated with SCC and ADC progression.

UR - http://www.scopus.com/inward/record.url?scp=77953105173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953105173&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-10-0142

DO - 10.1158/1078-0432.CCR-10-0142

M3 - Article

VL - 16

SP - 2979

EP - 2988

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 11

ER -